{
    "Orphapacket": {
        "ORPHApacketId": "420429",
        "creationDate": "2023-12-06 11:51:54",
        "version": "1.3.29 / 4.1.7 [2023-08-02] (orientdb version)",
        "copyright": "Orphanet (c) 2023",
        "ORPHAcode": "420429",
        "Label": "Glycogen storage disease due to acid maltase deficiency, late-onset",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_420429",
        "DisorderType": {
            "value": "Clinical subtype",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377796"
        },
        "Synonyms": [
            {
                "Synonym": "Alpha-1,4-glucosidase acid deficiency, late-onset"
            },
            {
                "Synonym": "GSD due to acid maltase deficiency, late-onset"
            },
            {
                "Synonym": "GSD type 2, late-onset"
            },
            {
                "Synonym": "GSD type II, late-onset"
            },
            {
                "Synonym": "Glycogen storage disease type 2, late-onset"
            },
            {
                "Synonym": "Glycogen storage disease type II, late-onset"
            },
            {
                "Synonym": "Glycogenosis type 2, late-onset"
            },
            {
                "Synonym": "Glycogenosis type II, late-onset"
            },
            {
                "Synonym": "Pompe disease, late-onset"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "232300",
                "DisorderMappingRelation": "NTBT (ORPHAcode is narrower than the targeted code used to represent it)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A form of glycogen storage disease due to acid maltase deficiency characterized by excessive accumulation of glycogen in lysosomes most notably in skeletal muscle leading to slowly progressive muscle weakness with walking disability and reduced respiratory function. The late-onset form includes all cases in which hypertrophic cardiomyopathy did not manifest or was not diagnosed at or under the age of 1 year as well as all cases with symptom onset above the age of 1 year."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "GAA",
                    "Name": "alpha glucosidase",
                    "ExternalReferences": [],
                    "DisorderGeneAssociationType": "Disease-causing germline mutation(s) in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "365",
                        "Label": "Glycogen storage disease due to acid maltase deficiency"
                    }
                ]
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "6789760[PMID]",
                    "PrevalenceType": "Prevalence at birth",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "1.75",
                    "PrevalenceGeographic": "Worldwide"
                }
            ]
        },
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Adolescent"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Adult"
                }
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal recessive"
                }
            ]
        }
    }
}